Cargando…
Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor
Loss-of-function mutations in the polycomb repressive complex 2 (PRC2) occur frequently in malignant peripheral nerve sheath tumor, an aggressive sarcoma that arises from NF1-deficient Schwann cells. To define the oncogenic mechanisms underlying PRC2 loss, we use engineered cells that dynamically re...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585487/ https://www.ncbi.nlm.nih.gov/pubmed/36130486 http://dx.doi.org/10.1016/j.celrep.2022.111363 |
_version_ | 1784813503862800384 |
---|---|
author | Zhang, Xiyuan Lou, Hannah E. Gopalan, Vishaka Liu, Zhihui Jafarah, Hilda M. Lei, Haiyan Jones, Paige Sayers, Carly M. Yohe, Marielle E. Chittiboina, Prashant Widemann, Brigitte C. Thiele, Carol J. Kelly, Michael C. Hannenhalli, Sridhar Shern, Jack F. |
author_facet | Zhang, Xiyuan Lou, Hannah E. Gopalan, Vishaka Liu, Zhihui Jafarah, Hilda M. Lei, Haiyan Jones, Paige Sayers, Carly M. Yohe, Marielle E. Chittiboina, Prashant Widemann, Brigitte C. Thiele, Carol J. Kelly, Michael C. Hannenhalli, Sridhar Shern, Jack F. |
author_sort | Zhang, Xiyuan |
collection | PubMed |
description | Loss-of-function mutations in the polycomb repressive complex 2 (PRC2) occur frequently in malignant peripheral nerve sheath tumor, an aggressive sarcoma that arises from NF1-deficient Schwann cells. To define the oncogenic mechanisms underlying PRC2 loss, we use engineered cells that dynamically reassemble a competent PRC2 coupled with single-cell sequencing from clinical samples. We discover a two-pronged oncogenic process: first, PRC2 loss leads to remodeling of the bivalent chromatin and enhancer landscape, causing the upregulation of developmentally regulated transcription factors that enforce a transcriptional circuit serving as the cell’s core vulnerability. Second, PRC2 loss reduces type I interferon signaling and antigen presentation as downstream consequences of hyperactivated Ras and its cross talk with STAT/IRF transcription factors. Mapping of the transcriptional program of these PRC2-deficient tumor cells onto a constructed developmental trajectory of normal Schwann cells reveals that changes induced by PRC2 loss enforce a cellular profile characteristic of a primitive mesenchymal neural crest stem cell. |
format | Online Article Text |
id | pubmed-9585487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-95854872022-10-21 Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor Zhang, Xiyuan Lou, Hannah E. Gopalan, Vishaka Liu, Zhihui Jafarah, Hilda M. Lei, Haiyan Jones, Paige Sayers, Carly M. Yohe, Marielle E. Chittiboina, Prashant Widemann, Brigitte C. Thiele, Carol J. Kelly, Michael C. Hannenhalli, Sridhar Shern, Jack F. Cell Rep Article Loss-of-function mutations in the polycomb repressive complex 2 (PRC2) occur frequently in malignant peripheral nerve sheath tumor, an aggressive sarcoma that arises from NF1-deficient Schwann cells. To define the oncogenic mechanisms underlying PRC2 loss, we use engineered cells that dynamically reassemble a competent PRC2 coupled with single-cell sequencing from clinical samples. We discover a two-pronged oncogenic process: first, PRC2 loss leads to remodeling of the bivalent chromatin and enhancer landscape, causing the upregulation of developmentally regulated transcription factors that enforce a transcriptional circuit serving as the cell’s core vulnerability. Second, PRC2 loss reduces type I interferon signaling and antigen presentation as downstream consequences of hyperactivated Ras and its cross talk with STAT/IRF transcription factors. Mapping of the transcriptional program of these PRC2-deficient tumor cells onto a constructed developmental trajectory of normal Schwann cells reveals that changes induced by PRC2 loss enforce a cellular profile characteristic of a primitive mesenchymal neural crest stem cell. 2022-09-20 /pmc/articles/PMC9585487/ /pubmed/36130486 http://dx.doi.org/10.1016/j.celrep.2022.111363 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Article Zhang, Xiyuan Lou, Hannah E. Gopalan, Vishaka Liu, Zhihui Jafarah, Hilda M. Lei, Haiyan Jones, Paige Sayers, Carly M. Yohe, Marielle E. Chittiboina, Prashant Widemann, Brigitte C. Thiele, Carol J. Kelly, Michael C. Hannenhalli, Sridhar Shern, Jack F. Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title | Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title_full | Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title_fullStr | Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title_full_unstemmed | Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title_short | Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor |
title_sort | single-cell sequencing reveals activation of core transcription factors in prc2-deficient malignant peripheral nerve sheath tumor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585487/ https://www.ncbi.nlm.nih.gov/pubmed/36130486 http://dx.doi.org/10.1016/j.celrep.2022.111363 |
work_keys_str_mv | AT zhangxiyuan singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT louhannahe singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT gopalanvishaka singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT liuzhihui singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT jafarahhildam singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT leihaiyan singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT jonespaige singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT sayerscarlym singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT yohemariellee singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT chittiboinaprashant singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT widemannbrigittec singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT thielecarolj singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT kellymichaelc singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT hannenhallisridhar singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor AT shernjackf singlecellsequencingrevealsactivationofcoretranscriptionfactorsinprc2deficientmalignantperipheralnervesheathtumor |